Biopharma Insights

FDA Recognizes SiSaf's siRNA Therapy, SIS-101-ADO, for Autosomal Dominant Osteopetrosis Treatment

In a noteworthy development in the pharmaceutical industry, SiSaf Ltd, a renowned RNA delivery and therapeutics firm, recently announced that …

Continue ›››

LabGenius Showcases AI-Driven Antibody Discovery Platform in a T-cell Engager Demonstration

London-based LabGenius, known for its innovative approach to antibody discovery, recently revealed impressive results from its research platform demonstration project. …

Continue ›››

The Rising Influence of Machine Learning and Coding in Biotechnology (a Survey)

The landscape of biotechnology is rapidly evolving, with coding and machine learning becoming integral to the innovative processes. A recent …

Continue ›››

Bruker Acquires ZONTAL, Boosting Digital Transformation in Pharma Laboratories

The pharmaceutical industry is undergoing a significant shift as digital transformation in pharma continues to reshape the landscape. Bruker Corporation, …

Continue ›››

Advancing Cell-free Biocomputing

Researchers from the University of Minnesota have published a study in Nature Communications introducing a new biocomputing method, Transcriptional RNA …

Continue ›››

From Qubits to Cures: The Promise of Quantum Computing in Pharmaceutical Research and Development (a Realistic View)

In a recent announcement, Moderna and IBM unveiled their partnership aimed at utilizing cutting-edge technologies, such as artificial intelligence (AI) …

Continue ›››

The Power of STB CLOUD in Remote AI Drug Discovery

STB CLOUD is Syntekabio’s latest cloud-based, fully automated AI platform. It’s designed for developers to engage in their drug discovery …

Continue ›››

AI Drug Discovery: Unleashing the Potential of Big Data and Machine Learning

The terms “big data”, “machine learning”, and “artificial intelligence” have been trending in the AI drug discovery space for several …

Continue ›››

RetinAI and Boehringer Ingelheim Collaborate on AI-Driven Drug Discovery for Geographic Atrophy Treatment

Established in 2017 in Swiss, RetinAI Medical AG is a notable player in clinical and imaging data management software and …

Continue ›››

Myricx Pharma Showcases Promising Pre-Clinical Data for NMTi ADC Programme at AACR

Myricx Pharma, an oncology drug discovery company specializing in precision medicines based on its N-myristoyltransferase (NMT) platform, has recently presented …

Continue ›››

Enamine and Endogena's Persistent Collaboration Paves the Way for Regenerative Medicine Advancements

In a world where innovation and collaboration play a critical role in the development of cutting-edge therapies, Enamine Ltd. and …

Continue ›››

Macomics Unveils ENIGMAC™ Discovery Platform at AACR for Target Validation in Macrophage Therapies

Macomics Ltd, a frontrunner in macrophage drug discovery, recently showcased its innovative ENIGMAC™ macrophage drug discovery platform at the American …

Continue ›››